PT  - JOURNAL ARTICLE
ED  - Markman, Maurie
AU  - Dreicer, Robert
TI  - The evolving role of hormone therapy in advanced prostate cancer
DP  - 2000 Oct 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 720--726
VI  - 67
IP  - 10
4099  - http://www.ccjm.org/content/67/10/720.short
4100  - http://www.ccjm.org/content/67/10/720.full
SO  - Cleve Clin J Med2000 Oct 01; 67
AB  - Earlier diagnosis and treatment of prostate cancer has changed the face of late-stage disease, and the use of mainstay hormonal therapies—orchiectomy, luteinizing hormone releasing-hormone analogs, and combined androgen ablation—are evolving rapidly. New approaches such as antiandrogen monotherapy and intermittent therapy are being evaluated. In addition, palliative treatments for patients with androgen-independent tumors have expanded.